|
Mechanism5-HT2A receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date13 Aug 2009 |
100 Clinical Results associated with LIAN HONG KONG LIMITED
0 Patents (Medical) associated with LIAN HONG KONG LIMITED
100 Deals associated with LIAN HONG KONG LIMITED
100 Translational Medicine associated with LIAN HONG KONG LIMITED